CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- 4 Grant or award Chief Executive Officer acquired 400,000 shares (grant or award)
- 4 Grant or award VP, Controller&Acct Principal acquired 75,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 125,000 shares (grant or award)
- 4 Grant or award Executive President acquired 100,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 175,000 shares (grant or award)
- 4 Open-market sale Chief Medical Officer sold 3,577 shares at $3.51 ($12,555)
- 4 Open-market sale Chief Executive Officer sold 8,273 shares at $3.51 ($29,038)
- 4 Open-market sale Chief Executive Officer sold 3,861 shares at $2.69 ($10,386)
- 4 Open-market sale Chief Medical Officer sold 1,211 shares at $2.69 ($3,258)
- 4 Open-market sale Chief Medical Officer sold 1,185 shares at an average $2.91 ($3,452)
- 4 Open-market sale Chief Executive Officer sold 1,207 shares at $2.81 ($3,392)
- 4 Open-market sale Chief Executive Officer sold 1,220 shares at $3.11 ($3,794)
- 4 Open-market sale Chief Medical Officer sold 1,205 shares at an average $5.70 ($6,870)
- 4 Open-market sale Chief Executive Officer sold 1,264 shares at $5.51 ($6,965)
- 4 Open-market sale Chief Executive Officer sold 1,350 shares at $7.26 ($9,801)
- 4 Open-market sale Chief Medical Officer sold 1,204 shares at $11.67 ($14,051)
- 4 Open-market sale Chief Executive Officer sold 1,228 shares at $11.67 ($14,331)
- 4 Open-market sale Chief Executive Officer sold 20,350 shares at $0.68 ($13,838)
- 4 Grant or award Director acquired 89,286 shares (grant or award)
- 4 Grant or award Director acquired 89,286 shares (grant or award)
Page 7 of 10 · 186 filings